Trials / Completed
CompletedNCT05244044
Pulmonary Rehabilitation for Long COVID (Post COVID-19 Condition)
Changes in Functional Exercise Capacity After PUlmonary REhabilitation in Primary Care: a Randomized, Controlled, Multicenter, Pragmatic Trial in 134 Patients With Long COVID (PuRe-COVID)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 76 (actual)
- Sponsor
- University Hospital, Antwerp · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In the PuRe COVID study (a randomized, controlled, multicenter, pragmatic trial) the investigators aim to assess the effect of a pulmonary rehabilitation program in primary care on exercise capacity (6MWT) and daily life physical activity in patients with long COVID. 134 patients with long COVID, defined by self-reported persistent COVID related symptoms ≥6 weeks after COVID-19 infection and a positive symptom score (CAT score ≥10 or mMRC score ≥2 or CIS-fatigue ≥36 or PCFS score of ≥2), will be recruited and divided into an intervention group or a control group. The intervention group will get twelve weeks of primary care pulmonary rehabilitation (PR) including coaching by primary care physiotherapists. The control group consists of usual care, which does not include a pulmonary rehabilitation program. This study will help determine whether the type of symptoms or affected body system can impact recovery form long covid during rehabilitation and after follow-up. The investigators will analyze determinants and risk factors that characterize non-responders and non-adherers to better understand which patients with long COVID benefit from rehabilitation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pulmonary rehabilitation in primary care | Pulmonary rehabilitation consists breathing exercises, exercise capacity, muscle strength and change towards an active lifestyle. |
Timeline
- Start date
- 2022-04-19
- Primary completion
- 2023-12-18
- Completion
- 2024-02-29
- First posted
- 2022-02-17
- Last updated
- 2024-10-01
Locations
2 sites across 1 country: Belgium
Source: ClinicalTrials.gov record NCT05244044. Inclusion in this directory is not an endorsement.